| Tocilizumab |
Influence on cell viability |
SRB assay |
0.01 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.01 µM |
UM-HMC-3A |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.01 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.01 µM |
HDMEC |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
UM-HMC-3A |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
HDMEC |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
1.00 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
1.00 µM |
UM-HMC-3A |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
1.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
1.00 µM |
HDMEC |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
10.00 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
10.00 µM |
UM-HMC-3A |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
10.00 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
10.00 µM |
HDMEC |
Homo sapiens |
|
|
|
